{"comparisonGroups":["Mock_18_days","X31_19_days"],"dateCreated":"2025-09-26 00:00:00","display_title":"Mock infection (18d) vs X31 virus infection (19d)","group_a_title":"Mock infected samples collected at 18 days post-infection. Serves as the reference point for all comparisons with infected groups.","group_b_title":"Samples infected with X31 virus collected at 19 days post-infection. Represents the maximum time point for X31 infection, providing insight into the long-term host response.","id":"MTBLS31_0001_00000007","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":4,"studyId":"MTBLS31","studyUrl":"http://integmet.org/study/MTBLS31","title":"Mock_18_days_vs_X31_19_days","topHits":[{"chebi_id":"15555","direction":"down","inn_name":"","iupac_name":"(5<i>Z</i>,13<i>E</i>,15<i>S</i>)-9\u03b1,15-dihydroxy-11-oxoprosta-5,13-dien-1-oic acid","metabolite_id":"BHMBVRSPMRCCGG-OUTUXVNYSA-N","pvalue":0.0132242935941999,"ratio":0.4753800771499886,"synonym_name":"(5Z,13E)-(15S)-9alpha,15-Dihydroxy-11-oxoprosta-5,13-dienoate"},{"chebi_id":"72663","direction":"up","inn_name":"","iupac_name":"(12<i>Z</i>)-9,10-dihydroxyoctadec-12-enoic acid","metabolite_id":"XEBKSQSGNGRGDW-YFHOEESVSA-N","pvalue":0.0199161518806636,"ratio":1.9641550841258228,"synonym_name":"9,10-DHOA"},{"chebi_id":"38299","direction":"up","inn_name":"","iupac_name":"(9<i>Z</i>)-11-(3-pentyloxiran-2-yl)undec-9-enoic acid","metabolite_id":"CCPPLLJZDQAOHD-FLIBITNWSA-N","pvalue":0.0289743364270087,"ratio":2.055346587855991,"synonym_name":"(9<i>Z</i>)-12,13-epoxyoctadecenoic acid"},{"chebi_id":"72665","direction":"up","inn_name":"","iupac_name":"(9<i>Z</i>)-12,13-dihydroxyoctadec-9-enoic acid","metabolite_id":"CQSLTKIXAJTQGA-FLIBITNWSA-N","pvalue":0.0215324519860253,"ratio":1.8560176433522368,"synonym_name":"12,13-DHOME"}],"totalFeatures":53}